Health ❯ Healthcare ❯ Biotechnology

Pharmaceuticals

Cystic Fibrosis Treatments Argenx SE AI in Healthcare Insmed Incorporated Cancer Treatment Antidotes Autoimmune Therapies Clinical Trials Drug Development Drug Approval Process

FDA Accepts ImmunityBio Filing to Expand ANKTIVA Use in Bladder Cancer

The FDA review sets a clear path for a potential label expansion pending a decision in early 2027.

Atara Investors Urged to Seek Lead Role in Securities Case Ahead of Deadline

Atara Faces Investor Class Action Over FDA Rejections of EBVALLO

Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Design

Investor Class Actions Target Atara Over FDA Setbacks to EBVALLO

BioAsia 2026 to Bring Global TechBio Leaders to Hyderabad on Feb. 17–18

France Authorizes Ricimed, Fabentech’s Antidote to Ricin

Artisan Mid Cap Fund Tops Benchmark in Q3, Shifts Toward Defense and Industrials

PGIM Jennison’s Q2 Letter Details Health-Care Slide, Portfolio Shifts and Company Catalysts

Cytokinetics Hit With Securities Class Action Over Aficamten Timeline Disclosures

Biotech Veterans Launch Corsera Health to Develop a Once‑Yearly RNAi Heart Prevention Shot

Biontech's Revenue Surges with Updated Covid-19 Vaccine